Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CardioCell

- PMLiVE

Takeda agrees $5.2bn deal to buy Ariad

Acquires cancer firm in the first big pharma M&A deal of 2017

- PMLiVE

Valeant uncouples Dendreon and skincare brands to cut debt

Agrees deals worth $2.1bn with L’Oreal and Sanpower Group

The Lucid Winter Summit

#LucidLife

Lucid Group Communications Limited

- PMLiVE

BMS names chairman of the board

Giovanni Caforio to succeed Lamberto Andreotti on 2 May

- PMLiVE

uniQure appoints chief executive officer

Matthew Kapusta takes up the lead role in a permanent capacity

PatientsLikeMe joins artificial intelligence alliance

The Digital Life Alliance is led by Chinese health-focused AI firm iCarbonX

ABPI London offices

ABPI film highlights value of the UK pharma industry

Campaign also includes online resources showing impact of UK-based research

- PMLiVE

The future of biotech

What impact will the sector, and its R&D performance, have on pharma?

- PMLiVE

2017 Trends in healthcare – how advances in technology are influencing the expert-patient relationship

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in...

Blue Latitude Health

- PMLiVE

Ipsen buys cancer business from stripped down Merrimack

Deal includes pancreatic cancer therapy Onivyde which it hopes will gain first-line approval

Novartis building

Novartis boosts cardiovascular pipeline with $1bn Ionis deal

Gains rights to two lipoprotein-targeting drugs currently in early-stage clinical development 

Bayer promotes Robert LaCaze

He becomes EVP of new oncology strategic business unit

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links